Immix Biopharma (IMMX) EPS (Basic) (2021 - 2026)
Quarterly results put EPS (Basic) at -$0.18 for Q1 2026, down 20.0% from a year ago — trailing twelve months through Mar 2026 was -$0.92 (down 31.43% YoY), and the annual figure for FY2025 was -$0.89, down 17.11%.
Immix Biopharma has reported EPS (Basic) over the past 6 years, most recently at -$0.18 for Q1 2026.
- EPS (Basic) reached -$0.18 in Q1 2026 per IMMX's latest filing, up from -$0.28 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$0.1 in Q1 2022 and bottomed at -$0.28 in Q4 2025.
- Median EPS (Basic) over the past 5 years was -$0.22 (2024), compared with a mean of -$0.2.
- The largest annual shift saw EPS (Basic) soared 95.62% in 2022 before it crashed 118.18% in 2023.
- Over 5 years, EPS (Basic) stood at -$0.27 in 2022, then rose by 11.11% to -$0.24 in 2023, then skyrocketed by 33.33% to -$0.16 in 2024, then crashed by 75.0% to -$0.28 in 2025, then soared by 35.71% to -$0.18 in 2026.
- Business Quant data shows EPS (Basic) for IMMX at -$0.18 in Q1 2026, -$0.28 in Q4 2025, and -$0.24 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 3.06 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 0.00 |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 0.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 4.06 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 6.99 |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 0.00 |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 1.55 |
| 10 | Immix Biopharma | 476.17 Mn | 476.17 Mn | - | -0.18 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.18 |
| Dec 31, 2025 | -0.28 |
| Sep 30, 2025 | -0.24 |
| Jun 30, 2025 | -0.22 |
| Mar 31, 2025 | -0.15 |
| Dec 31, 2024 | -0.16 |
| Sep 30, 2024 | -0.24 |
| Jun 30, 2024 | -0.15 |
| Mar 31, 2024 | -0.22 |
| Dec 31, 2023 | -0.24 |
| Sep 30, 2023 | -0.23 |
| Jun 30, 2023 | -0.24 |
| Mar 31, 2023 | -0.18 |
| Dec 31, 2022 | -0.27 |
| Sep 30, 2022 | -0.11 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.10 |
| Dec 31, 2021 | -6.16 |
| Sep 30, 2021 | -0.12 |
| Jun 30, 2021 | -0.06 |
| Mar 31, 2021 | -0.30 |